NIOX GroupCSSPF 77 Forward Dividend Yield % is 2.56% as of Jun. 24, 2026. GuruFocus rates CSSPF with a GF Score™ of 77/100 and a GF Value™ of $1.21 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 316 Medical Devices & Instruments companies, NIOX Group ranks better than 61.39% on this metric.
As of today (2026-06-24), the Forward Annual Dividend Yield of NIOX Group is 2.56%.
As of today (2026-06-24), the Trailing Annual Dividend Yield of NIOX Group is 2.56%.
CSSPF's Forward Dividend Yield % is ranked better than 61.39% of 316
companies
in the Medical Devices & Instruments industry
Industry Median: 2.095
vs CSSPF: 2.56
During the past 12 months, NIOX Group's average Dividends Per Share Growth Rate was 30.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
NIOX Group (OTCPK:CSSPF) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
CSSPF vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, NIOX Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NIOX Group Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NIOX Group's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where NIOX Group's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
NIOX Group Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
GBP 0.015500
2026-05-21
2026-05-22
2026-06-22
Cash Dividend
annually
GBP:USD 1.349528
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
NIOX Group's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.020917684
/
0.79965
=
2.62 %
Current Share Price is $0.79965. NIOX Group's Dividends per Share for the forward twelve months is calculated as $0.020917684 * 1 = $0.020917684.
NIOX Group's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.020917684
/
0.79965
=
2.62 %
Current Share Price is $0.79965. NIOX Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.020917684.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.56% mean?
NIOX Group (CSSPF) has a Forward Dividend Yield % of 2.56% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on NIOX Group and its competitors. According to the industry distribution chart, NIOX Group ranks #122 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 38.6%.
Is NIOX Group's Forward Dividend Yield % too high?
NIOX Group's current Forward Dividend Yield % is 2.56%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.10. NIOX Group's value of 2.56% is 22.2% above this industry median. Based on the distribution chart, NIOX Group ranks #122 out of 316 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, NIOX Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NIOX Group's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NIOX Group ranks #122 out of 316 companies for Forward Dividend Yield %. This puts NIOX Group in the upper half of its industry. The industry median Forward Dividend Yield % is 2.10. NIOX Group's value of 2.56% is 22.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.10, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NIOX Group's current Forward Dividend Yield % of 2.56% is 22.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on NIOX Group and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NIOX Group's current Forward Dividend Yield % is 2.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NIOX Group stock overvalued right now?
Based on GuruFocus' analysis, NIOX Group (CSSPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $1.21, compared to a current price of $0.80 — trading 33.9% below its estimated fair value. The current Forward Dividend Yield % is 2.56% and 22.2% above the Medical Devices & Instruments industry median of 2.10. NIOX Group's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For NIOX Group (CSSPF), the current Forward Dividend Yield % is 2.56% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NIOX Group (CSSPF) Overvalued in 2026?
Based on GuruFocus' analysis, NIOX Group stock appears to be undervalued.
The current stock price of $0.80 is trading 33.9% below its estimated GF Value™ of $1.21.
GuruFocus considers NIOX Group to be Significantly Undervalued.
Key valuation signals for CSSPF:
Forward Dividend Yield %: 2.56%
GF Value™: $1.21 vs. price of $0.80 (33.9% below fair value)
Industry Position: 22.2% above the Medical Devices & Instruments median (#122 of 316)
No single metric tells the full story. See the CSSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NIOX Group PLC is engaged in improving the diagnosis, monitoring and management of both asthma and COPD by providing greater patient access to FeNO testing. The company is engaged in the design, development, and commercialization of medical devices for the measurement of FeNO, a precise biomarker for type 2 inflammation which is present in asthma and COPD. Its device, NIOX VERO, is increasingly recognised by healthcare professionals as an important tool to improve the diagnosis, monitoring and management of asthma and COPD. It operates in single segment of NIOX relates to the portfolio of products used to improve asthma diagnosis, monitoring and management by measuring fractional exhaled nitric oxide (FeNO).
77GF Score
Get the complete analysis for CSSPF
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSSPF has been successfully added to your 